Cofoe Medical Technology Co.,Ltd.
1187.HK
30.18
HKD
+0.14
- -
ISIN
CNE100007KH4
Return %
Stock
S&P500
1Y
-22.42
23.08
3Y
-22.42
67.59
5Y
-22.42
74.74
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Min Zhang
- Full Time Employees
- 5,081
- Sector
- Healthcare
- Industry
- Medical - Specialties
- Address
- Changsha People's Republic of China
- IPO Date
- May 6, 2026
- Website
- cofoe.com.cn
- Similar Companies
- Business
- Cofoe Medical Technology Co., Ltd. engages in the research, development, production, sales, and service of home care medical devices in China. The company provides a broad portfolio of medical and wellness products designed for disease treatment, rehabilitation, daily health maintenance, and life quality enhancement; including rehabilitation aids such as hearing aids, electric wheelchairs, and orthopedic/posture correction devices; medical care products including dressing and ostomy care; health monitoring devices such as metabolic disease testing products and thermometers; respiratory support equipment including non-invasive ventilators and nebulizers; traditional Chinese medicine therapy devices and other physiotherapy equipment. It operates across multiple product categories, brands, and service types intended for consumer and professional use, with emphasis on home-use medical devices and related accessories. The company manufactures, markets, and services these products through a network of subsidiaries and branch companies, targeting consumers, pharmacies, distributors, and e-commerce platforms. Cofoe maintains a significant emphasis on R&D and product innovation, seeking to expand online and offline sales channels while enhancing digitalized operations and brand influence. Headquarters are in China, and the company maintains a broad geographic footprint within the country to support nationwide distribution, with ongoing expansion into overseas markets and collaboration with partners to advance AI-enabled, digitalized home care medical solutions. Founded in 2000, the company states a substantial footprint through numerous subsidiaries and holding structures, underscoring its role as a leading professional household medical devices manufacturer in its region. Cofoe is positioned to provide integrated solutions across its core product categories, including blood pressure monitors, thermometers, nebulizers, oxygen concentrators, hearing aids, glucose meters, ostomy supplies, wheelchairs, hospital beds, and related DME, supported by ongoing product development, regulatory compliance, and quality assurance programs to meet market and customer requirements. The company reports active engagement in strategic alliances, funding events, and capacity upgrades as part of its latest corporate developments to strengthen market presence and accelerate growth.